Maternal disease activity and serological activity as predictors of adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective chart review

被引：0
|
作者：
Tsuyoshi Murata
Hyo Kyozuka
Toma Fukuda
Naoya Toba
Aya Kanno
Shun Yasuda
Akiko Yamaguchi
Yasuhisa Nomura
Takashi Kanno
Kiyoshi Migita
Keiya Fujimori
机构：
[1] Fukushima Medical University School of Medicine,Department of Obstetrics and Gynecology
[2] Ohta-Nishinouchi Hospital,Department of Obstetrics and Gynecology
[3] Ohta-Nishinouchi Hospital,Department of Rheumatology
[4] Fukushima Medical University School of Medicine,Department of Rheumatology
来源：
Archives of Gynecology and Obstetrics | 2022年 / 305卷
关键词：
Systemic lupus erythematosus; Disease activity; Autoantibody; Hypocomplementemia; Adverse pregnancy outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1177 / 1183
页数：6
相关论文
共 50 条
  • [41] Hematologic Disorder during Pregnancy Associated with Adverse Pregnancy Outcomes Among Women with Systemic Lupus Erythematosus
    Tedeschi, Sara K.
    Guan, Hongshu
    Fine, Alexander
    Lu, Bing
    Costenbader, Karen H.
    Bermas, Bonnie
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] PREGNANCY IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS: MATERNAL AND FETAL COMPLICATIONS
    Kirsanova, Tatiana
    Tsatsulina, Olga
    Vinogradova, Maria
    Fedorova, Tatiana
    Rozina, Nina
    Rumyantseva, Elizaveta
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 2109 - 2110
  • [43] Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study
    Chen, Dongying
    Lao, Minxi
    Zhang, Jianyu
    Zhan, Yanfeng
    Li, Weinian
    Cai, Xiaoyan
    Zhan, Zhongping
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [44] Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus
    Zhan, Zhongping
    Yang, Ying
    Zhan, Yanfeng
    Chen, Dongying
    Liang, Liuqin
    Yang, Xiuyan
    PLOS ONE, 2017, 12 (04):
  • [45] ATTAINMENT OF LUPUS LOW DISEASE ACTIVITY STATE EXCLUSIVE OF REMISSION IS PROTECTIVE AGAINST ADVERSE OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Kandane-Rathnayake, R.
    Golder, V.
    Louthrenoo, W.
    Chen, Y. H.
    Cho, J.
    Lateef, A.
    Hamijoyo, L.
    Luo, S. F.
    Wu, Y. J. Jan
    Navarra, S.
    Zamora, L.
    Li, Z.
    Sockalingam, S.
    Katsumata, Y.
    Harigai, M.
    Hao, Y.
    Zhang, Z.
    Basnayake, B.
    Chan, M.
    Kikuchi, J.
    Takeuchi, T.
    Oon, S.
    Bae, S. C.
    O'neill, S.
    Goldblatt, F.
    Ng, K.
    Law, A.
    Tugnet, N.
    Kumar, S.
    Tee, M.
    Tee, C.
    Tanaka, Y.
    Lau, C. S.
    Nikpour, M.
    Hoi, A.
    Morand, E. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 149 - 150
  • [46] Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients with Systemic Lupus Erythematosus
    Kim, Ji-Won
    Jung, Ju-Yang
    Kim, Hyoun-Ah
    Suh, Chang-Hee
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [47] Lupus Low Disease Activity State Achievement Is Important for Reducing Adverse Outcomes in Pregnant Patients With Systemic Lupus Erythematosus
    Kim, Ji-Won
    Jung, Ju-Yang
    Kim, Hyoun-Ah
    Yang, Jeong, I
    Kwak, Dong W.
    Suh, Chang-Hee
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (05) : 707 - 716
  • [48] Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus
    Vitali, C
    Bencivelli, W
    Mosca, M
    Carrai, P
    Sereni, M
    Bombardieri, S
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (02) : 498 - 501
  • [49] Does Obesity Affect Disease Activity Outcomes in Systemic Lupus Erythematosus?
    Tselios, Konstantinos
    Gladman, Dafna
    Su, Jiandong
    Urowitz, Murray
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1790 - 1793
  • [50] Patterns of High Disease Activity Status and Outcomes in Systemic Lupus Erythematosus
    Hoi, Alberta
    Nim, Hieu
    Koelmeyer, Rachel
    Sun, Ying
    Kao, Amy
    Guenther, Oliver
    Morand, Eric
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345